Tejaswi Ramananda Nadig

Tejaswi Ramananda Nadig practices at MUSC University Hospital in Charleston, South Carolina.

Tejaswi Ramananda Nadig's NPI, 1942720495, was assigned on June 26, 2017. Tejaswi Ramananda Nadig holds South Carolina license PENDING.

Tejaswi Ramananda Nadig's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Tejaswi Ramananda Nadig's primary practice is MUSC University Hospital in Charleston, South Carolina. Tejaswi Ramananda Nadig is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Tejaswi Ramananda Nadig to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tejaswi Ramananda Nadig practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Tejaswi Ramananda Nadig's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Tejaswi Ramananda Nadig is licensed in South Carolina.

CMS data shows 315 Medicare services from Tejaswi Ramananda Nadig across 7 procedure codes in 2024, for 175 Medicare patients. Medicare paid $27,914 for them.

CMS counts 175 Medicare patients who saw Tejaswi Ramananda Nadig in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tejaswi Ramananda Nadig's median patient age at 66, with 60% women.

In 2024, Tejaswi Ramananda Nadig wrote 164 Medicare Part D claims for 61 patients. CMS names the drug for 88 of them, across 5 drugs with 11 or more claims each, at $57,943 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Tejaswi Ramananda Nadig for performance year 2024, reported as part of a group. Tejaswi Ramananda Nadig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tejaswi Ramananda Nadig as offering telehealth.

CMS Open Payments shows 22 general payments to Tejaswi Ramananda Nadig from 7 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 56% of the total. Medtronic, Inc. paid the most, $1,048.